Watch our webinar with experts from Lachman Consultants, Regenxbio, PPD and Etena Therapeutics as we discuss key consideration of successful CGT manufacturing and quality strategies.
Key discussions include:
- Developing a successful regulatory strategy in the evolving CGT field
- Achieving CGT quality and compliance through effective quality systems implementation
- Navigating increasing CGT manufacturing demand and capacity and scalability challenge
- Avoiding quality and compliance issues to ensure patient access
CELL AND GENE THERAPY
ADDITIONAL RESOURCES
CELL AND GENE THERAPIES
RECENT BLOG POSTS
Getting a CRISPR View - Genetic Editing: Medical Frontier
Most of us in the pharmaceutical industry have heard the phrase “targeted therapy”. Targeted therapies are drugs or other substances specifically designed to prevent cancer cells from dividing or destroying them directly, and are intended to target only cancer cells...
The Ever-Evolving World of Combination Products
Ricki A. Chase, M.S, Lachman Consultants, wrote a recent article for Contract Pharma looking at the benefits and challenges of the trend towards combination products. Here is a brief excerpt from the article: “As the life sciences industries have continued to evolve, the need for ever changing nomenclature has evolved along with it...